Organic sales decreased 1.6% driven by lower pricing as a result of ongoing strategic investments in price-pack architecture and enhancing value propositions across our portfolio. Volume and mix were flat compared to the prior year.

The 2024 Transformation Initiative is expected to be completed by the end of 2026 with total pre-tax savings of $3.0 billion in gross productivity, inclusive of input cost and manufacturing cost savings, and $200 million in selling, general and administrative expenses.

Beginning in March 2022, the company significantly adjusted its business in Russia, substantially curtailing media, advertising and promotional activity and suspending capital investments, other than certain maintenance investments, in its sole manufacturing facility in Russia.

For the three months ended March 31, 2025, total 2024 Transformation Initiative charges were $77 million pre-tax ($77 million after-tax). Cumulative pre-tax charges for the 2024 Transformation Initiative were $534 million ($416 million after-tax) through March 31, 2025.

In the fourth quarter of 2024, Kimberly-Clark realigned its internal operating and management structure as part of the 2024 Transformation Initiative. The company now manages and reports its operations through three reportable segments defined by geographic regions and product groupings.

Capital spending was $204 million compared to $194 million in the prior year. Full year capital spending is anticipated to be approximately $1.0 to $1.2 billion, including incremental spending from the 2024 Transformation Initiative.

The United States announced a new universal baseline tariff of 10%, plus an additional country-specific tariff for select trading partners, on all U.S. imports. These actions are estimated to increase incremental costs of approximately $300 million in 2025.

The company acknowledges that its ability to continue operations in Russia may change as the situation evolves, and that its assets may be partially or fully impaired.

The company has evaluated the effects of the Global anti-Base Erosion rules set forth by the Organization for Economic Co-Operation and Development, and determined the impact will be immaterial to its financial results.

Organic sales decreased 2.3% driven by lower pricing, reflecting actions taken in response to increased competition in the United Kingdom, Latin America and Australia.

Organic sales decreased 1.6% driven by lower pricing as a result of ongoing strategic investments in price-pack architecture and enhancing value propositions across our portfolio.

Organic sales decreased 0.6% due to lower pricing, reflecting strategic investments to optimize our product offerings and value propositions across consumer and professional channels.

The 2024 Transformation Initiative aims to generate $3.0 billion in gross productivity savings, inclusive of input cost and manufacturing cost savings, and $200 million in selling, general and administrative expenses.

Adjusted gross margin decreased 20 basis points to 36.9% primarily due to higher manufacturing costs and unfavorable pricing net of cost inflation, partially offset by gross productivity savings from integrated margin management of approximately $110.

Cash provided by operations was $327 million compared to $438 million in the prior year. The decrease was driven by lower operating profit and unfavorable changes in operating working capital, including higher cash payments related to the 2024 Transformation Initiative.

The 2024 Transformation Initiative is designed to sharpen strategic focus through a new operating model that leverages three synergistic forces, including accelerating pioneering innovation to capture significant growth available in our categories by investing in science and technology to satisfy unmet and evolving consumer needs.

The 2024 Transformation Initiative focuses on optimizing margin structure to deliver superior consumer propositions and implement initiatives and deploy technology and data analytics designed to create a fast, adaptable, integrated supply chain with greater visibility that can deliver continuous improvement.

The filing mentions accelerating innovation and technology investments, but does not provide specific details on R&D spending or technological capabilities.

During the three months ended March 31, 2025, the company repurchased 458 thousand shares of its common stock pursuant to its publicly announced share repurchase programs at a total cost of $61 million.

Capital spending was $204 million compared to $194 million in the prior year. The company anticipates that full year capital spending will be approximately $1.0 to $1.2 billion, including incremental spending from the 2024 Transformation Initiative.

Cash used for financing was $683 million compared to $485 million in the prior year. This increase was primarily due to debt repayments during the current year.

The provided excerpt does not contain any specific details regarding environmental commitments, social responsibility initiatives, or governance practices.

Consistent with the humanitarian nature of our products, we manufacture and sell only essential items in Russia, such as baby diapers and feminine pads, which are critical to the health and hygiene of women, girls and babies.

Net sales of $4.8 billion for the three months ended March 31, 2025 declined 6.0% primarily due to unfavorable currency impacts.

Based on preliminary analysis of the potential effects of the new tariffs that are currently in effect in the U.S. as well as in other markets in which we operate, we estimate incremental costs of approximately $300 in 2025.

Organic sales decreased 2.3% driven by lower pricing, reflecting actions taken in response to increased competition in the United Kingdom, Latin America and Australia.